Covid-19

Nes Ziona, Israel, April 13, 2020 - Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the Israel Innovation Authority (IIA) selected the Company’s planned COVID-19 and sepsis clinical programs to receive, in the aggregate, a non-dilutive grant of approximately $1.5 million for the period through the first quarter of 2021. To … [Read more...] about Enlivex Selected by the Israel Innovation Authority to Receive $1.5 Million Grant to Fund COVID-19 and Sepsis Clinical Trials

All treated patients were in Intensive Care Units (ICU) on ventilators and suffered from Acute Respiratory Distress Syndrome (ARDS) 100% survival rate for all seven patients 6 patients completed 1 week follow up; the seventh patient was treated on April 5 2020 4 of the 6 (66%) patients that completed 1 week follow up demonstrated improvement in respiratory … [Read more...] about Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure

$300 Million Advanced To Social Service Agencies Globally And An Emergency Fund of $4.3 Million Established For Social Service Agencies Providing Life-Saving Assistance Julius Berman, President of the Conference on Jewish Material Claims Against Germany (Claims Conference), today announced a Holocaust survivor emergency assistance fund to help address emergency needs … [Read more...] about Claims Conference Establishes Special Emergency Fund For Holocaust Survivors During The COVID-19 Crisis

NETANYA, Israel, March 24, 2020 - CLEW today announced that its TeleICU solution – CLEW-ICU – is being deployed by Tel Aviv Sourasky Medical Center (Ichilov Hospital) and Sheba Medical Center as an innovative new way to manage and treat patients infected with the COVID-19 virus while protecting frontline care workers. In anticipation of a surge in ICU admissions, both … [Read more...] about Leading Israeli Hospitals Launch CLEW AI-based TeleICU to Support COVID-19 Crisis

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J. - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the U.S. to … [Read more...] about Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide